资讯
As-needed albuterol–budesonide significantly reduced severe exacerbations and steroid use compared to albuterol alone in mild asthma patients with uncontrolled symptoms.
Background: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) measured the global prevalence and severity of asthma symptoms in children. Methods: A cross-sectional ...
In children with significant respiratory distress, we initiate a dose of either 75 mg/hr (half diluted 5 mg/mL) albuterol solution delivered via a HEART nebulizer (High-output Extended Aerosol ...
An alleged risk of patients breathing in or swallowing small particles of foam from degrading sleep aids has prompted the federal government to take legal action. Multinational health technology ...
The spreading epidemic of allergies and asthma has heightened interest in IgE, the central player in the allergic response. The activity of IgE is associated with a network of proteins ...
[2] Short-acting β-adrenergic receptor agonists are the drugs of choice for treating acute asthma exacerbation. Of these drugs, albuterol is almost exclusively used. Albuterol MDIs are normally ...
21 天
MyChesCo on MSNAstraZeneca’s BATURA Trial Highlights Breakthrough Results for Asthma TreatmentAstraZeneca has announced groundbreaking results from the BATURA Phase IIIb trial for AIRSUPRA (albuterol/budesonide), marking a significant advancement in asthma care. The anti-inflammatory rescue ...
The US Food and Drug Administration (FDA) has approved treprostinil inhalation powder (YUTREPIA), a prostacyclin analog designed to enhance exercise capacity in adults with pulmonary arterial ...
The low-effort inhalation device used to deliver YUTREPIA may make it easier to start and maintain patients on treatment, especially those with limited inspiratory flows or lung capacity.” Matt ...
F RIDAY, May 23, 2025 (HealthDay News) -- As-needed albuterol-budesonide yields a lower risk for severe asthma exacerbation among patients with mild asthma, according to a study published online ...
As a chronic disease, asthma symptoms can be brought on by seasonal allergies, pollution, exercise, or even weather changes. On Wednesday, the U.S. Food and Drug Administration (FDA) announced a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果